In 1993, only 16,800 procedures were reported. That number jumped to 370,000 in 2009. Once offered only to patients who needed to lose more than 100 pounds, concerns about obesity-related conditions, such as diabetes and heart disease, have opened the procedure up to patients with a BMI as low as 30. An increase in cancer diagnoses and procedures is also expected to contribute to market growth.
Related Articles on Gastroenterology:
EndoChoice to Receive Georgia Bio Deal of the Year Award
Gastrointestinal Endoscopic Device Market Expected to Hit $2.7B by 2018
KY’s Jennie Stuart ASC Celebrates 5th Anniversary, Adds Barrett’s Esophagus Treatment
